2020
DOI: 10.1016/j.nut.2019.110697
|View full text |Cite
|
Sign up to set email alerts
|

Validation and improvement of the predictive equation for resting energy expenditure in advanced gastrointestinal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 24 publications
0
1
0
1
Order By: Relevance
“…[ 65 ] When evaluated in terms of the cancer type, normal rate of REE was observed in patients with breast, melanoma, gastric, or colorectal cancer in some studies,[ 39 66 ] while hypermetabolism was seen in patients with pancreatic or lung cancer. [ 66 ] In addition, in studies in which REE was evaluated by indirect calorimetry, it was reported that 57% of the 140 patients with head and neck cancer[ 67 ] and 56.9% of 109 patients with advanced gastrointestinal cancer[ 68 ] were hypermetabolic and most were malnourished. In addition to the type of cancer, its stage also affects REE.…”
Section: Discussionmentioning
confidence: 99%
“…[ 65 ] When evaluated in terms of the cancer type, normal rate of REE was observed in patients with breast, melanoma, gastric, or colorectal cancer in some studies,[ 39 66 ] while hypermetabolism was seen in patients with pancreatic or lung cancer. [ 66 ] In addition, in studies in which REE was evaluated by indirect calorimetry, it was reported that 57% of the 140 patients with head and neck cancer[ 67 ] and 56.9% of 109 patients with advanced gastrointestinal cancer[ 68 ] were hypermetabolic and most were malnourished. In addition to the type of cancer, its stage also affects REE.…”
Section: Discussionmentioning
confidence: 99%
“…Estudo multicêntrico brasileiro, que avaliou 4.783 pacientes com câncer pela ferramenta ASG-PPP, verificou que os tumores de tórax tiveram uma maior associação com desnutrição (OR 4,59, intervalo de confiança de 95% (IC) 3,18-6,63, p<0.001), seguido pelos tumores do aparelho digestivo superior (OR 4,51, IC 95% 3,31-6,1, p<0.001) e de cabeça e pescoço (OR 3,70, IC 95% 2,66-5,15, p<0.001) (159). Além desses sítios tumorais apresentarem sintomas gastrointestinais que impactam na ingesta alimentar, evidências científicas apontam aumento no gasto energético em repouso o que justificam maior percentual de desnutrição nesse grupo de pacientes (160)(161)(162).…”
Section: 3) Sitio Tumoral Comprometimento Nutricional E Câncerunclassified